Gregory Alan Korbel

Insider Reports History

Location
Boston, MA
Signature
/s/ Scott M. Coiante, attorney-in-fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Gregory Alan Korbel:

Company Role Class Num Shares Value Price $ Report Date Ownership
Aprea Therapeutics, Inc. SVP, Chief Operating Officer Common Stock 45,762 $168,445 $3.68 28 Jul 2022 Direct
Aprea Therapeutics, Inc. SVP, Chief Operating Officer Stock Option (right to Buy) 35,700 28 Jul 2022 Direct

Insider Reports Filed by Gregory Alan Korbel

Symbol Company Period Transactions Value $ Form Type Role Filing Time
APRE Aprea Therapeutics, Inc. 28 Jul 2022 2 $0 4 SVP, Chief Operating Officer 01 Aug 2022, 17:04
APRE Aprea Therapeutics, Inc. 03 Jun 2022 1 -$6,754 4 SVP, Chief Operating Officer, Director 07 Jun 2022, 17:01
APRE Aprea Therapeutics, Inc. 10 Mar 2022 3 -$3,620 4 SVP, Chief Business Officer, Director 14 Mar 2022, 17:03
APRE Aprea Therapeutics, Inc. 25 Feb 2022 1 -$2,307 4 SVP, Chief Business Officer 01 Mar 2022, 16:02
APRE Aprea Therapeutics, Inc. 01 Dec 2021 3 -$83,600 4 SVP, Chief Business Officer 03 Dec 2021, 16:01
APRE Aprea Therapeutics, Inc. 01 Nov 2021 4 -$112,200 4 SVP, Chief Business Officer 03 Nov 2021, 17:34
APRE Aprea Therapeutics, Inc. 01 Oct 2021 3 -$109,175 4 SVP, Chief Business Officer 05 Oct 2021, 17:01
APRE Aprea Therapeutics, Inc. 20 Sep 2021 4 -$138,566 4 SVP, Chief Business Officer 22 Sep 2021, 17:01
APRE Aprea Therapeutics, Inc. 10 Sep 2021 1 -$7,913 4 Chief Business Officer 14 Sep 2021, 17:01
APRE Aprea Therapeutics, Inc. 25 Aug 2021 1 -$4,573 4 Chief Business Officer 27 Aug 2021, 17:02